Participation of OCRL1, and APPL1, in the expression, proteolysis, phosphorylation and endosomal trafficking of megalin: Implications for Lowe Syndrome.
APPL1
GSK3
insulin
lowe syndrome
megalin
ocrl1
proteolysis
renal disease
Journal
Frontiers in cell and developmental biology
ISSN: 2296-634X
Titre abrégé: Front Cell Dev Biol
Pays: Switzerland
ID NLM: 101630250
Informations de publication
Date de publication:
2022
2022
Historique:
received:
03
04
2022
accepted:
10
10
2022
entrez:
7
11
2022
pubmed:
8
11
2022
medline:
8
11
2022
Statut:
epublish
Résumé
Megalin/LRP2 is the primary multiligand receptor for the re-absorption of low molecular weight proteins in the proximal renal tubule. Its function is significantly dependent on its endosomal trafficking. Megalin recycling from endosomal compartments is altered in an X-linked disease called Lowe Syndrome (LS), caused by mutations in the gene encoding for the phosphatidylinositol 5-phosphatase OCRL1. LS patients show increased low-molecular-weight proteins with reduced levels of megalin ectodomain in the urine and accumulation of the receptor in endosomal compartments of the proximal tubule cells. To gain insight into the deregulation of megalin in the LS condition, we silenced OCRL1 in different cell lines to evaluate megalin expression finding that it is post-transcriptionally regulated. As an indication of megalin proteolysis, we detect the ectodomain of the receptor in the culture media. Remarkably, in OCRL1 silenced cells, megalin ectodomain secretion appeared significantly reduced, according to the observation in the urine of LS patients. Besides, the silencing of APPL1, a Rab5 effector associated with OCRL1 in endocytic vesicles, also reduced the presence of megalin's ectodomain in the culture media. In both silencing conditions, megalin cell surface levels were significantly decreased. Considering that GSK3ß-mediated megalin phosphorylation reduces receptor recycling, we determined that the endosomal distribution of megalin depends on its phosphorylation status and OCRL1 function. As a physiologic regulator of GSK3ß, we focused on insulin signaling that reduces kinase activity. Accordingly, megalin phosphorylation was significantly reduced by insulin in wild-type cells. Moreover, even though in cells with low activity of OCRL1 the insulin response was reduced, the phosphorylation of megalin was significantly decreased and the receptor at the cell surface increased, suggesting a protective role of insulin in a LS cellular model.
Identifiants
pubmed: 36340038
doi: 10.3389/fcell.2022.911664
pii: 911664
pmc: PMC9630597
doi:
Types de publication
Journal Article
Langues
eng
Pagination
911664Informations de copyright
Copyright © 2022 Sandoval, Fuentealba and Marzolo.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
PLoS One. 2014 Apr 04;9(4):e93672
pubmed: 24705369
Nat Commun. 2016 May 16;7:11550
pubmed: 27180806
Prostate. 2008 Apr 1;68(5):463-76
pubmed: 18196535
Sci Rep. 2019 Feb 18;9(1):2207
pubmed: 30778159
J Biol Chem. 2004 Mar 5;279(10):9331-6
pubmed: 14665622
Endocrinology. 2009 Feb;150(2):871-8
pubmed: 18927221
J Biol Chem. 2000 Jan 28;275(4):2568-75
pubmed: 10644715
Mol Aspects Med. 2008 Oct;29(5):258-89
pubmed: 18762209
Hum Mol Genet. 2020 Jun 27;29(10):1700-1715
pubmed: 32391547
Dev Cell. 2009 Nov;17(5):712-23
pubmed: 19922875
Pharmacol Ther. 2006 Sep;111(3):985-1006
pubmed: 16626807
Traffic. 2007 Sep;8(9):1215-30
pubmed: 17555532
Genomics. 1995 Oct 10;29(3):598-606
pubmed: 8575751
Pediatr Nephrol. 2017 Apr;32(4):621-625
pubmed: 27766457
J Biol Chem. 2004 Aug 13;279(33):34302-10
pubmed: 15180987
J Am Soc Nephrol. 2011 Mar;22(3):443-8
pubmed: 21183592
Mol Biol Cell. 2011 Mar 1;22(5):606-23
pubmed: 21233288
Traffic. 2013 Jul;14(7):823-38
pubmed: 23593972
J Biol Chem. 1998 Jan 16;273(3):1574-82
pubmed: 9430698
Mol Cell Biol. 1998 Jul;18(7):3862-70
pubmed: 9632770
Nature. 2001 Dec 13;414(6865):799-806
pubmed: 11742412
Diabetes Care. 2009 Jul;32(7):1266-8
pubmed: 19366958
Diabetes Care. 2012 May;35(5):1112-8
pubmed: 22410816
EMBO J. 2006 Aug 23;25(16):3750-61
pubmed: 16902405
Pediatr Nephrol. 2016 Dec;31(12):2201-2212
pubmed: 27011217
J Biol Chem. 2000 Jun 2;275(22):17187-94
pubmed: 10747918
AMA Am J Dis Child. 1952 Feb;83(2):164-84
pubmed: 14884753
Mol Biol Cell. 2005 Aug;16(8):3467-79
pubmed: 15917292
J Exp Biol. 2009 Jun;212(Pt 11):1630-7
pubmed: 19448073
PLoS One. 2014 Dec 12;9(12):e114400
pubmed: 25502002
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8472-7
pubmed: 12815097
Biochem J. 2022 Jun 17;479(11):1237-1256
pubmed: 35594055
Biol Res. 2011;44(1):89-105
pubmed: 21720686
Genes Cells. 2007 Dec;12(12):1315-27
pubmed: 18076569
Traffic. 2003 Apr;4(4):273-88
pubmed: 12694565
Semin Cell Dev Biol. 2009 Apr;20(2):138-45
pubmed: 18840536
J Am Soc Nephrol. 1995 Jul;6(1):35-47
pubmed: 7579068
Mol Genet Metab. 2006 Sep-Oct;89(1-2):121-8
pubmed: 16777452
Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L807-L824
pubmed: 28705909
Hum Mol Genet. 2019 Jun 15;28(12):1931-1946
pubmed: 30590522
Biochem J. 2004 Aug 15;382(Pt 1):363-73
pubmed: 15130087
J Biol Chem. 2010 Nov 26;285(48):37531-41
pubmed: 20876574
Am J Physiol Cell Physiol. 2014 Mar 1;306(5):C441-9
pubmed: 24153428
EMBO J. 2011 Oct 04;30(24):4970-85
pubmed: 21971085
PLoS One. 2019 May 23;14(5):e0213127
pubmed: 31120873
Cell Rep. 2014 May 22;7(4):1227-38
pubmed: 24813896
EMBO Rep. 2021 Jul 5;22(7):e52173
pubmed: 33987909
Biochem Biophys Res Commun. 2008 May 2;369(2):493-9
pubmed: 18307981
Kidney Blood Press Res. 2019;44(3):298-330
pubmed: 31185475
Curr Med Chem. 2009;16(15):1917-48
pubmed: 19442155
Mol Cell Biol. 1987 Aug;7(8):2745-52
pubmed: 3670292
J Biol Chem. 2001 Mar 23;276(12):9352-8
pubmed: 11116142
PLoS One. 2011 Feb 02;6(2):e16794
pubmed: 21311715
Methods. 2017 Feb 15;115:28-41
pubmed: 28057586
Nat Rev Nephrol. 2017 Aug;13(8):455-470
pubmed: 28669993
Kidney Int. 2001 Nov;60(5):1885-92
pubmed: 11703607
Nephron Physiol. 2009;112(2):p27-36
pubmed: 19390221
Pediatr Nephrol. 2020 Apr;35(4):641-648
pubmed: 31811534
J Biol Chem. 2012 Apr 13;287(16):13128-36
pubmed: 22351770
J Cell Sci. 2014 Sep 15;127(Pt 18):3893-901
pubmed: 25015290
Mol Cell Biol. 2006 Dec;26(23):8928-41
pubmed: 17000777
Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1191-F1207
pubmed: 29949391
Int J Mol Sci. 2016 May 20;17(5):
pubmed: 27213360
Am J Pathol. 1999 Oct;155(4):1361-70
pubmed: 10514418
J Nephrol. 2022 Jan;35(1):201-210
pubmed: 33646560
Oncogene. 1999 Sep 2;18(35):4891-8
pubmed: 10490823
J Biol Chem. 2011 Dec 16;286(50):43405-16
pubmed: 22002060
Dev Cell. 2007 Sep;13(3):377-90
pubmed: 17765681
Nat Cell Biol. 2011 Jun 26;13(8):981-8
pubmed: 21706022
Nucleic Acids Res. 2001 May 1;29(9):e45
pubmed: 11328886
J Am Soc Nephrol. 2002 Jan;13(1):125-133
pubmed: 11752029
J Am Soc Nephrol. 2004 Apr;15(4):892-900
pubmed: 15034091
Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9725-9
pubmed: 7937880
ACS Chem Biol. 2014 Jun 20;9(6):1359-68
pubmed: 24742366
J Microsc. 2006 Dec;224(Pt 3):213-32
pubmed: 17210054
Int J Mol Sci. 2021 Jun 29;22(13):
pubmed: 34209489
PLoS Genet. 2015 Apr 02;11(4):e1005058
pubmed: 25838181
Int J Mol Sci. 2022 Jan 13;23(2):
pubmed: 35055044
Mol Biol Cell. 2012 Jan;23(1):176-87
pubmed: 22072788
Diabetes. 2017 May;66(5):1391-1404
pubmed: 28289043
Cell. 2008 May 2;133(3):486-97
pubmed: 18455989
J Cell Biochem. 2008 Dec 1;105(5):1211-8
pubmed: 18802920
Annu Rev Physiol. 2017 Feb 10;79:425-448
pubmed: 27813828
Nature. 1995 Dec 21-28;378(6559):785-9
pubmed: 8524413
Clin J Am Soc Nephrol. 2008 Sep;3(5):1430-6
pubmed: 18480301
Am J Physiol Cell Physiol. 2008 Aug;295(2):C529-37
pubmed: 18495814
Am J Pathol. 1993 Aug;143(2):598-611
pubmed: 8342605
Mol Cell Proteomics. 2008 Jun;7(6):1031-42
pubmed: 18256213
FASEB J. 2003 Feb;17(2):247-9
pubmed: 12475886
Nature. 1992 Jul 16;358(6383):239-42
pubmed: 1321346
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13368-73
pubmed: 15326289
J Am Soc Nephrol. 2015 Nov;26(11):2669-77
pubmed: 25817355